Skip navigation

Industry Best Practices and Strategies for Managing and Enhancing Ethics and Integrity Programs

June 2-3, 2020
  • Montreal, Canada

CBI’s 4th Annual Pharmaceutical Compliance Congress Canada convenes top Canadian compliance practitioners and leading experts to discuss effective strategies to achieve organization-wide compliance, from the compliance and legal teams to the oversight of the promotional marketing and sales teams. Join your Canadian colleagues for robust conversations on the top issues facing industry today.

Key Learnings & Take-aways Include:

  • Implement innovative strategies to enhance
    compliance training and monitoring
  • Elevating compliance to the role of strategic partner
  • Examine how the changes in Health Canada codes impact industry
  • Construct ethical interactions with stakeholders —
    Transitioning to relationship management
  • Engage the organization in supporting a culture of
    compliance and ethics —
    Connect the benefits of compliance to the business at large
  • Engage HCPs —
    Consider international trends in global transparency reporting
  • Discuss risk mitigation strategies and best practices for
    OLAs, PSPs and MSLs
  • Manage risk in working with third parties — Consider how to manage risks related to data protection/cyber security
  • Explore the digitization of medicine & medical education and
    its impact on compliance
  • And so much more!
    Be the first to see the 2020 agenda — Request your copy today

PREVIOUS ATTENDEE ACCLAIM:

Very well organized, well run conference with great speakers and sessions that provided in-depth knowledge to participants.

Vice President, Ontario & Marketing, MEDtech Canada

Always a great opportunity to learn from colleagues across
the broader pharmaceutical industry, key stakeholders
and other relevant collaborators.

Head, Pharma Integrity & Compliance, Novartis Pharmaceutical UK Ltd

Very informative and well-organized conference. Worth attending as it not only provides good insight into important and relevant industry issues, but it provides you with an opportunity to network with Compliance colleagues.

Director, Ethics & Compliance, Leo Pharma Inc.

The conference is on-point for anyone in the compliance world in Canada.

Medical Compliance, Janssen

It was great learning what worked and didn’t work for other companies in terms of raising the awareness of compliance with my own respective pharmaceutical company.

Compliance Specialist, Sanofi-Pasteur

Excellent conference!
Worth taking two days from work.

Chief Compliance Officer, Boehringer Ingelheim

4th Annual Pharmaceutical Compliance Congress Canada

Industry Best Practices and Strategies for Managing and Enhancing Ethics and Integrity Programs

CBI’s 4th Annual Pharmaceutical Compliance Congress Canada convenes top Canadian compliance practitioners and leading experts to discuss effective strategies to achieve organization-wide compliance, from the compliance and legal teams to the oversight of the promotional marketing and sales teams. Join your Canadian colleagues for robust conversations on the top issues facing industry today.

Key Learnings & Take-aways Include:

  • Implement innovative strategies to enhance
    compliance training and monitoring
  • Elevating compliance to the role of strategic partner
  • Examine how the changes in Health Canada codes impact industry
  • Construct ethical interactions with stakeholders —
    Transitioning to relationship management
  • Engage the organization in supporting a culture of
    compliance and ethics —
    Connect the benefits of compliance to the business at large
  • Engage HCPs —
    Consider international trends in global transparency reporting
  • Discuss risk mitigation strategies and best practices for
    OLAs, PSPs and MSLs
  • Manage risk in working with third parties — Consider how to manage risks related to data protection/cyber security
  • Explore the digitization of medicine & medical education and
    its impact on compliance
  • And so much more!
    Be the first to see the 2020 agenda — Request your copy today

PREVIOUS ATTENDEE ACCLAIM:

Very well organized, well run conference with great speakers and sessions that provided in-depth knowledge to participants.

Vice President, Ontario & Marketing, MEDtech Canada

Always a great opportunity to learn from colleagues across
the broader pharmaceutical industry, key stakeholders
and other relevant collaborators.

Head, Pharma Integrity & Compliance, Novartis Pharmaceutical UK Ltd

Very informative and well-organized conference. Worth attending as it not only provides good insight into important and relevant industry issues, but it provides you with an opportunity to network with Compliance colleagues.

Director, Ethics & Compliance, Leo Pharma Inc.

The conference is on-point for anyone in the compliance world in Canada.

Medical Compliance, Janssen

It was great learning what worked and didn’t work for other companies in terms of raising the awareness of compliance with my own respective pharmaceutical company.

Compliance Specialist, Sanofi-Pasteur

Excellent conference!
Worth taking two days from work.

Chief Compliance Officer, Boehringer Ingelheim